With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.
We are looking to continue expanding our Target Identification teams by bringing in a number of innovative and highly creative drug discovery scientists with a background in molecular pharmacology and/or molecular and cellular biology, particularly in the context of pathological mechanisms underlying human diseases. You will make significant contributions to our technology-enabled drug discovery programmes by generating novel therapeutic target hypotheses and delivering robust preclinical target validation data packages. You will apply your deep understanding of biological processes and drug discovery to rapidly move projects through preclinical research and development. This is a non-lab position, based at our London offices, where you will work closely with experts in drug discovery, artificial intelligence, informatics, patient stratification, clinical translation and commercialisation
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey. If that sounds like a fit for you, hit the apply button and join us.
BenevolentAI unites AI with human expertise to discover new and more effective medicines. Our unique computational R&D platform spans every step of the drug discovery process, powering an in-house pipeline of over 25 drug programmes. We advance our mission to reinvent drug discovery by harnessing the power of a diverse team, rich with different backgrounds, experiences, opinions and personalities. In our offices in London and New York and research facility in Cambridge (UK), we work in highly collaborative, multidisciplinary teams, harnessing skills across biology, chemistry, engineering, AI, machine learning, informatics, precision medicine and drug discovery.
Our team will only contact you from the domain @benevolent.ai. If you receive a suspicious contact request, please email firstname.lastname@example.org. Thank you.